1. P563 Monitoring of vedolizumab drug levels in a treat to target strategy for moderate-severe IBD (MOVE-IBD). (30th January 2023) Authors: Logan, H; Rimmer, K; Doecke, J; Patrick, D Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗